NCT02622659 - The Efficacy and Safety Study of Fuganlin Oral Liquid in Children With Influenza (Acute Upper Respiratory Infection) | Biotech Hunter

Enrollment

468

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions

Acute Upper Respiratory Infection

Interventions

DRUG

Fuganlin Oral Liquid

"less than 1 years old: 5mL each time and three times a day~1\~3 years old: 10mL each time and three times a day~4\~6 years old: 10mL each time and four times a day~7\~12 years old: 10mL each time and five times a day"

DRUG

Xiaoer Jiebiao Oral Liquid

"1\~2 years old: 5mL each time and twice a day~3\~5 years old: 5mL each time and three times a day~6\~14 years old: 10mL each time and twice a day"

Trial Locations (1)

462000

Luohe traditional Chinese medicine hospital, Luohe